Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Availability of vaccine no guarantee public will want it

01.12.2009
Just because a vaccine is available doesn't mean people will choose to be inoculated, according to new UofT research published amid widespread public confusion around the merit of H1N1 flu shots.

The research – which looked at acceptability of potential future HIV vaccinations among high-risk adults in Los Angeles – shows many factors come into play when a person is deciding whether or not be vaccinated.

"As we can see in the current climate of confusion around H1N1 flu shots, the availability of a vaccination alone is not enough to encourage people to be inoculated," says lead author Peter A. Newman, associate professor at UofT's Factor-Inwentash Faculty of Social Work and Canada Research Chair in Health and Social Justice. "Our study shows the same holds true when it comes to potential HIV vaccines down the road. Even in the case of a safe and highly effective vaccine, there are a plethora of factors that impact peoples' decisions."

To determine what factors would make a vaccine "acceptable" to individuals at-risk of contracting HIV, Newman and his team gave each of 1,100 participants a set of nine cards outlining theoretical HIV vaccines. Each card described a theoretical HIV vaccine with a different combination of characteristics, including vaccine effectiveness, cost and side effects. Participants were then asked to rate the "acceptability" of each vaccine according to what vaccine characteristics were most and least important to them.

The team found a moderate level of acceptability for a future HIV vaccine – 55 on a 100-point scale. But while the moderate level of acceptability is positive, Newman says their results indicate that not everyone – including those in high-risk communities – would automatically accept an HIV vaccine in the event that one was developed.

The factors that most influenced participants' acceptance of the theoretical vaccines were efficacy (how effective a vaccine would be against HIV) followed by side effects and cost. The team also found that about 10 percent of at-risk adults might increase their sexual risk behaviours – such as not using condoms – if vaccinated against HIV.

"Merely having a vaccine available doesn't mean it gets to the people who need it – a fact that is evidenced by the issues we're seeing now around H1N1 vaccines," says Newman. "If we want HIV vaccines to be acceptable and accessible to people, we need to consider all of these factors before we have a safe and relatively effective vaccine on the market."

Education is key, says Newman. People need to trust that a vaccine is good and will be effective. They need to understand in lay terms how it works. They need to know what scientists mean when they talk about a vaccine's efficacy, and they need to know they shouldn't increase their risk behaviours simply because they're being vaccinated. Initial HIV vaccines may be only partially effective in preventing HIV infection; they may be a great addition to existing prevention methods, but not a replacement.

The research also indicates that governments should consider how to subsidize vaccines to make sure they are affordable to those who are least able to pay.

Newman says the study provides a template that should be replicated in the developing world, which carries 95 percent of the global HIV burden.

"In order to ensure future HIV vaccines are acceptable to those who need them, we must start acting now," says Newman. "Formative research that aims to anticipate and address consumer preferences and larger challenges in the introduction of new health and prevention technologies is a cost-effective means to promote success."

For more information on the study, appearing in the December edition of Health Services Research, please contact:

Peter A. Newman, lead author: p.newman@utoronto.ca

April Kemick, media relations officer: 416-978-5949 or april.kemick@utoronto.ca

April Kemick | EurekAlert!
Further information:
http://www.utoronto.ca

Further reports about: Availability H1N1 HIV HIV vaccine Social Impacts health services

More articles from Health and Medicine:

nachricht Cystic fibrosis alters the structure of mucus in airways
28.06.2017 | University of Iowa Health Care

nachricht Mice provide insight into genetics of autism spectrum disorders
28.06.2017 | University of California - Davis

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Supersensitive through quantum entanglement

28.06.2017 | Physics and Astronomy

X-ray photoelectron spectroscopy under real ambient pressure conditions

28.06.2017 | Physics and Astronomy

Mice provide insight into genetics of autism spectrum disorders

28.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>